Investors

Latest Announcements

24.11.25
Press Release

Shareholder Announcement - THE UNIVERSITY OF SYDNEY EXECUTES SITE AGREEMENT TO PROGRESS PHASE II CLINICAL TRIAL INTO ALCOHOL USE DISORDER

Read More
14.04.25
Press Release

SHAREHOLDER ANNOUNCEMENT MACQUARIE UNIVERSITY MICRODEP TRIAL SET TO ENTER NEXT PHASE OF RESEARCH

Read More
06.11.24
Press Release

WOKE PHARMACEUTICALS AND UWA FILE A PROVISIONAL PATENT FOR NEW, SIMPLIFIED LSD ANALOGUES

Read More
20.09.24
Press Release

WOKE EXTENDS RESEARCH PARTNERSHIP WITH UNIVERSITY OF WESTERN AUSTRALIA FOLLOWING DISCOVERY OF 55 NEW LSD COMPOUNDS

Read More
View All

Latest Presentations

View All

Latest Media

03.03.23
Media

Australia is about to legalise MDMA and psilocybin for medicinal use. So how will it work?

Read More
30.01.23
Media

Australia’s biggest research trial using psychedelics to treat depression | Swinburne University of Technology

Read More
22.12.22
Media

Trial to explore the use of psychedelics for alcohol use disorder

Read More
21.10.22
Media

Biotech Daily: Dr Boreham's Crucible on Woke

Read More
View All

ACN: 651 290 729

Address: Suite 301, 10 Bridge St, Sydney NSW 2000 Australia

Email: info@wokeph.com